# Sodium Bicarbonate Supplementation in Chronic Kidney Disease Evaluation of Dose Response, Safety and Beneficial Effects

> **NCT00888290** · PHASE2,PHASE3 · COMPLETED · sponsor: **Albert Einstein College of Medicine** · enrollment: 20 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** Sodium bicarbonate
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT00888290
- **Lead sponsor:** Albert Einstein College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00888290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00888290, "Sodium Bicarbonate Supplementation in Chronic Kidney Disease Evaluation of Dose Response, Safety and Beneficial Effects". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT00888290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*